Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Fraence Hardtstock, Julia Krieger, Thomas Wilke, Marco Lukas, Bernhard Ultsch, Robert Welte, Renate Quinzler, Ulf Maywald & Hartmut Timmermann. (2023) Epidemiology, treatment and health care resource use of patients with severe asthma in Germany – a retrospective claims data analysis. Journal of Asthma 60:7, pages 1280-1289.
Read now
Read now
Fraence Hardtstock, Julia Krieger, Thomas Wilke, Marco Lukas, Bernhard Ultsch, Robert Welte, Renate Quinzler, Ulf Maywald & Hartmut Timmermann. (2022) Use of Biologic Therapies in the Treatment of Asthma – A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation. Journal of Asthma and Allergy 15, pages 407-418.
Read now
Read now
Stephanie Chen, Sarowar Golam, Julie Myers, Chris Bly, Harry Smolen & Xiao Xu. (2018) Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Current Medical Research and Opinion 34:12, pages 2075-2088.
Read now
Read now
Erwin C Vasbinder, Svetlana V Belitser, Patrick C Souverein, Liset van Dijk, Arnold G Vulto & Patricia MLA van den Bemt. (2016) Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children. Patient Preference and Adherence 10, pages 531-538.
Read now
Read now
Gregory S. Sawicki, Yury Vilk, Michael Schatz, Ken Kleinman, Allyson Abrams & Jeanne Madden. (2010) Uncontrolled Asthma in a Commercially Insured Population From 2002 to 2007: Trends, Predictors, and Costs. Journal of Asthma 47:5, pages 574-580.
Read now
Read now
Bonnie B. Dean, Brian M. Calimlim, Sylvia L. Kindermann, Rezaul K. Khandker & David Tinkelman. (2009) The Impact of Uncontrolled Asthma on Absenteeism and Health-Related Quality of Life. Journal of Asthma 46:9, pages 861-866.
Read now
Read now
Articles from other publishers (13)
Daniel Doberer, Humberto E. Trejo Bittar & Sally E. Wenzel. (2015) Should lung biopsies be performed in patients with severe asthma?. European Respiratory Review 24:137, pages 525-539.
Crossref
Crossref
Kate McKeage. (2015) Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists. Drugs 75:7, pages 809-816.
Crossref
Crossref
Allan T. Luskin, Bradley E. Chipps, Lawrence Rasouliyan, Dave P. Miller, Tmirah Haselkorn & Alejandro Dorenbaum. (2014) Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma. The Journal of Allergy and Clinical Immunology: In Practice 2:5, pages 544-552.e2.
Crossref
Crossref
Benjamin J. Green, Surasa Wiriyachaiporn, Christopher Grainge, Geraint B. Rogers, Valia Kehagia, Laurie Lau, Mary P. Carroll, Kenneth D. Bruce & Peter H. Howarth. (2014) Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma. PLoS ONE 9:6, pages e100645.
Crossref
Crossref
Erika H. De Boever, Claire Ashman, Anthony P. Cahn, Nicholas W. Locantore, Phil Overend, Isabelle J. Pouliquen, Adrian P. Serone, Tracey J. Wright, Mair M. Jenkins, Inderpal S. Panesar, Sivayogan S. Thiagarajah & Sally E. Wenzel. (2014) Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial. Journal of Allergy and Clinical Immunology 133:4, pages 989-996.e4.
Crossref
Crossref
Kate McKeage. (2013) Omalizumab: A Review of its Use in Patients with Severe Persistent Allergic Asthma. Drugs 73:11, pages 1197-1212.
Crossref
Crossref
Robert S. Zeiger, Ashley Yegin, F. Estelle R. Simons, Tmirah Haselkorn, Lawrence Rasouliyan, Stanley J. Szefler & Bradley E. Chipps. (2012) Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. Annals of Allergy, Asthma & Immunology 108:2, pages 81-87.e3.
Crossref
Crossref
Erika J SimsDavid PriceJohn HaughneyDermot RyanMike Thomas. (2011) Current Control and Future Risk in Asthma Management. Allergy, Asthma and Immunology Research 3:4, pages 217.
Crossref
Crossref
Tmirah Haselkorn, Hubert Chen, Dave P. Miller, James E. Fish, Stephen P. Peters, Scott T. Weiss & Craig A. Jones. (2010) Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) Study. Annals of Allergy, Asthma & Immunology 104:6, pages 471-477.
Crossref
Crossref
Karin J. Velthove, Patrick C. Souverein, Wouter W. van Solinge, Hubert G. M. Leufkens & Jan-Willem J. Lammers. (2010) Measuring exacerbations in obstructive lung disease. Pharmacoepidemiology and Drug Safety 19:4, pages 367-374.
Crossref
Crossref
Karin J. Velthove, Patrick C. Souverein, Wouter W. van Solinge, Hubert G.M. Leufkens & Jan-Willem J. Lammers. (2010) Effects of corticosteroid use on readmission in obstructive lung disease. Respiratory Medicine 104:2, pages 211-218.
Crossref
Crossref
Tmirah Haselkorn, James E. Fish, Robert S. Zeiger, Stanley J. Szefler, Dave P. Miller, Bradley E. Chipps, F. Estelle R. Simons, Scott T. Weiss, Sally E. Wenzel, Larry Borish & Eugene R. Bleecker. (2009) Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Journal of Allergy and Clinical Immunology 124:5, pages 895-902.e4.
Crossref
Crossref
Richard J. Betts & D. Michael Kemeny. (2009) CD8+ T cells in asthma: Friend or foe?. Pharmacology & Therapeutics 121:2, pages 123-131.
Crossref
Crossref